Arthritis Pain Formula Drug Interactions
Currently displaying 71 drugs known to have a major interaction with Arthritis Pain Formula (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide).
- 71 major drug interactions
- 524 moderate drug interactions
- 64 minor drug interactions
Major interactions with Arthritis Pain Formula (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
Note: Showing generic names only.
- abrocitinib
- acalabrutinib
- acetazolamide
- ado-trastuzumab emtansine
- aducanumab
- anisindione
- apixaban
- ardeparin
- avapritinib
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- desirudin
- dichlorphenamide
- dicumarol
- dolutegravir
- donanemab
- dorzolamide ophthalmic
- doxercalciferol
- drotrecogin alfa
- ibritumomab
- ibrutinib
- ibuprofen
- infigratinib
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- inotersen
- iodine i 131 tositumomab
Arthritis Pain Formula alcohol/food interactions
There are 4 alcohol/food interactions with Arthritis Pain Formula (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide).
Arthritis Pain Formula disease interactions
There are 18 disease interactions with Arthritis Pain Formula (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide) which include:
- constipation
- coagulation
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Arthritis Pain Formula (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.